Eugenio Caturelli
Viterbo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma.
Journal: Hepatology international
Published: November 14, 2024
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 15, 2023
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 17, 2022
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: January 23, 2022
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment.
Journal: Frontiers in oncology
Published: November 25, 2021
Contrast-Enhanced Ultrasound Findings in Patients with Rare Solitary Necrotic Nodule of the Liver - a Multicenter Report.
Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)
Published: August 25, 2021
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 10, 2021
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting.
Journal: Journal of clinical medicine
Published: June 01, 2021
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 12, 2021
Last Updated: 09/26/2026